ORBIMED ADVISORS LLC 13D/13G Filings for Galecto, Inc. (GLTO)

ORBIMED ADVISORS LLC 13D and 13G filings for Galecto, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-09-18
4:19 pm
Sale
2023-09-1213DGalecto, Inc.
GLTO
ORBIMED ADVISORS LLC29,982
2.800%
-16,005decrease
(-34.80%)
Filing
2023-09-05
4:20 pm
Sale
2023-08-3013DGalecto, Inc.
GLTO
ORBIMED ADVISORS LLC45,988
4.200%
-18,315decrease
(-28.48%)
Filing
2023-08-17
4:30 pm
Sale
2023-08-1513DGalecto, Inc.
GLTO
ORBIMED ADVISORS LLC64,303
5.900%
-25,354decrease
(-28.28%)
Filing
2023-08-02
5:02 pm
Sale
2023-07-3113DGalecto, Inc.
GLTO
ORBIMED ADVISORS LLC89,658
8.300%
-8,568decrease
(-8.72%)
Filing
2023-07-17
4:11 pm
Sale
2023-07-1313DGalecto, Inc.
GLTO
ORBIMED ADVISORS LLC98,226
9.600%
-9,641decrease
(-8.94%)
Filing
2023-04-07
4:38 pm
Sale
2023-04-0513DGalecto, Inc.
GLTO
ORBIMED ADVISORS LLC107,866
10.500%
-2,992decrease
(-2.70%)
Filing
2020-11-06
5:12 pm
Purchase
2020-10-2913DGalecto, Inc.
GLTO
ORBIMED ADVISORS LLC110,858
11.300%
110,858increase
(New Position)
Filing